Literature DB >> 8989677

A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I.

L J Shaw1, R Hachamovitch, E L Eisenstein, K L Kesler, G V Heller, D D Miller.   

Abstract

This review presents a brief overview of existing diagnostic and prognostic methodologies to be used for the evaluation of patients undergoing noninvasive testing. In part I of this review, we will present methods for use of logistic and Cox regression analyses in determining the diagnostic and prognostic value of nuclear imaging techniques. In part II of this review, we will present an outline for the integration of economic evaluations into the clinical decision-making process. This review will document how cost estimates may be defined as well as the differing type of cost analyses (i.e., cost efficiency versus cost-effectiveness).

Entities:  

Mesh：

Year:  1996        PMID： 8989677     DOI： 10.1016/s1071-3581(96)90062-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  21 in total

1.  Prognostic value of dipyridamole thallium-201 imaging in elderly patients.

Authors:  L Shaw; B R Chaitman; T C Hilton; K Stocke; L T Younis; D G Caralis; B A Kong; D D Miller
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  A comparison of multivariable mathematical methods for predicting survival--I. Introduction, rationale, and general strategy.

Authors:  A R Feinstein; C K Wells; S D Walter
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

4.  A comparison of multivariable mathematical methods for predicting survival--II. Statistical selection of prognostic variables.

Authors:  S D Walter; A R Feinstein; C K Wells
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

5.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; N J Lembo; W S Weintraub; A S Kosinski; H X Barnhart; M H Kutner; N P Alazraki; R A Guyton; X Q Zhao
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

6.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

7.  Gender-related differences in clinical management after exercise nuclear testing.

Authors:  R Hachamovitch; D S Berman; H Kiat; N Bairey-Merz; I Cohen; J A Cabico; J D Friedman; G Germano; K F Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

8.  Estimating the likelihood of significant coronary artery disease.

Authors:  D B Pryor; F E Harrell; K L Lee; R M Califf; R A Rosati
Journal:  Am J Med       Date:  1983-11       Impact factor: 4.965

9.  Value of the history and physical in identifying patients at increased risk for coronary artery disease.

Authors:  D B Pryor; L Shaw; C B McCants; K L Lee; D B Mark; F E Harrell; L H Muhlbaier; R M Califf
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

10.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321
View more
  4 in total

Review 1.  Statistical analysis of medical data. Part I: Univariable analysis.

Authors:  R Hachamovitch; C Shufelt
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Prognostic characterization of patients with mild coronary artery disease with myocardial perfusion single photon emission computed tomography: validation of an outcomes-based strategy.

Authors:  R Hachamovitch
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

3.  Cardiovascular risk assessment models: Have we found the perfect solution yet?

Authors:  Aiden Abidov; Omar Chehab
Journal:  J Nucl Cardiol       Date:  2019-02-21       Impact factor: 5.952

4.  Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group.

Authors:  L J Shaw; G V Heller; M I Travin; M Lauer; T Marwick; R Hachamovitch; D S Berman; D D Miller
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.